Jane Street Group, LLC Clearside Biomedical, Inc. Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.08 - $1.58 $159,854 - $233,860	-148,013 Reduced 83.76%	28,693 $37,000
Q1 2024 May 15, 2024	BUY	$1.2 - $2.02 $212,047 - $356,946	176,706 New	176,706 $270,000
Q2 2023 Aug 14, 2023	BUY	$0.97 - $1.48 $15,467 - $23,600	15,946 New	15,946 $17,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $14,232 - $21,348	14,232 New	14,232 $15,000
Q2 2022 Aug 16, 2022	SELL	$1.3 - $2.49 $112,080 - $214,677	-86,216 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.35 - $2.88 $88,322 - $188,421	65,424 Added 314.66%	86,216 $197,000
Q4 2021 Feb 15, 2022	BUY	$2.72 - $5.72 $56,554 - $118,930	20,792 New	20,792 $57,000
Q3 2020 Nov 17, 2020	SELL	$1.45 - $2.0 $80,254 - $110,696	-55,348 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.55 - $2.41 $21,672 - $33,696	13,982 Added 33.8%	55,348 $104,000
Q1 2020 May 15, 2020	BUY	$1.32 - $3.77 $54,603 - $155,949	41,366 New	41,366 $70,000
Q3 2019 Nov 14, 2019	SELL	$0.59 - $1.32 $59,315 - $132,704	-100,534 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$0.97 - $1.42 $97,517 - $142,758	100,534 New	100,534 $98,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.